XRAY vs KMTS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

XRAY

44.3
AI Score
VS
XRAY Wins

KMTS

35.6
AI Score

Investment Advisor Scores

XRAY

44score
Recommendation
HOLD

KMTS

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY KMTS Winner
Forward P/E 6.3291 0 Tie
PEG Ratio 0.633 0 Tie
Revenue Growth -4.1% 59.9% KMTS
Earnings Growth 15.2% 0.0% XRAY
Tradestie Score 44.3/100 35.6/100 XRAY
Profit Margin -15.0% -140.4% XRAY
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -18.8% · 3M: -25.0% KMTS 1M: +7.9% · 3M: +0.5%

Current Technical Phase

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

KMTS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 57

RSI (14): 56.5 · Price: $27.12

Fundamentals Snapshot

Metric XRAY KMTS
Market Cap — —
Forward P/E 5.8 -12.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.6%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% -1.2%
EPS -2.69 -2.67
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.